Docebo Q2 2024 Adj. EPS $0.26 Beats $0.13 Estimate, Sales $53.054M Beat $52.295M Estimate
Portfolio Pulse from Benzinga Newsdesk
Docebo (NASDAQ:DCBO) reported Q2 2024 adjusted EPS of $0.26, beating the $0.13 estimate by 100%. Sales were $53.054M, surpassing the $52.295M estimate and marking a 21.70% increase from the same period last year.
August 08, 2024 | 10:17 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Docebo (NASDAQ:DCBO) reported strong Q2 2024 results with EPS of $0.26, beating estimates by 100%, and sales of $53.054M, surpassing estimates by 1.45%. This indicates robust financial performance and significant growth.
The significant beat on both EPS and sales estimates, along with strong year-over-year growth, suggests positive market sentiment and potential short-term price appreciation for Docebo's stock.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100